Lisinopril Cost in Alaska 2026: Cash Price, Medicaid, Insurance, and Savings Options

At a glance
- Cash price (2026) / ~$8 per month at Alaska retail pharmacies
- Manufacturer list price / ~$50 per month before discounts
- Alaska Medicaid coverage / requires prior authorization; not on standard preferred drug list
- Compounded lisinopril (503A) / legal in Alaska; may cost $0 out-of-pocket through some programs
- Telehealth prescribing / fully legal in Alaska
- Standard dose form / oral tablet, taken once daily
- FDA-approved indications / hypertension, heart failure, post-MI, diabetic nephropathy
- Most common dose range / 5 mg to 40 mg daily
- Generic availability / yes, since patent expiry; multiple manufacturers
- GoodRx-style discount cards / widely accepted at Alaska pharmacies; can reduce cost below $8
What Is Lisinopril and Why Does It Matter in Alaska?
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor approved by the FDA for hypertension, systolic heart failure, and acute myocardial infarction management, as well as diabetic nephropathy at off-label doses. [1] Alaska has one of the highest rates of cardiovascular risk factors in the United States, with CDC data showing that roughly 32% of Alaskan adults reported high blood pressure in recent surveillance cycles. [2] That burden makes access to affordable antihypertensive medication a genuine public-health priority.
The drug works by blocking ACE, which reduces formation of angiotensin II and thereby lowers vascular resistance and blood pressure. Its efficacy is not theoretical. The ALLHAT trial (N=33,357), published in JAMA 2002, compared lisinopril head-to-head against chlorthalidone and amlodipine in high-risk hypertensive patients. Chlorthalidone was superior for some outcomes, but lisinopril still produced meaningful blood-pressure reduction and remained a first-line option per JNC guidelines. [3] The FDA product label confirms lisinopril's approval across multiple cardiovascular indications. [4]
Because generic lisinopril has been available for years, it sits in a price range that most Alaskan patients can reach. [5] The challenge is knowing exactly which channel, pharmacy, or coverage path gets it to you most cheaply.
Lisinopril Cash Price in Alaska in 2026
The average cash price at Alaska retail pharmacies in 2026 is approximately $8 per month for a 30-tablet supply of standard doses (5 mg, 10 mg, or 20 mg). That figure covers the most common 10 mg strength. Higher doses such as 40 mg may cost slightly more, but rarely above $12 to $15 per month without any discount card.
The manufacturer list price for branded or reference-listed generic products is roughly $50 per month, a gap that exists because no single pharmacy is obligated to pass wholesaler rebates directly to cash-paying patients. [6] Using a pharmacy benefit manager discount card or a manufacturer coupon closes most of that gap. GoodRx, Cost Plus Drugs, and RxSaver all operate in Alaska and routinely show lisinopril below $10 at Anchorage, Fairbanks, and Juneau pharmacies.
Rural Alaska presents a logistics challenge. Patients in remote villages serviced by mail-order pharmacies should request a 90-day supply, which typically costs $20 to $24 cash and reduces per-unit shipping overhead. The National Institute of Health notes that medication adherence improves with 90-day versus 30-day supplies. [7] For a patient in Bethel or Nome, ordering a quarter-year supply at once is both cheaper and more practical.
Walmart and Costco pharmacies in Anchorage and the Matanuska-Susitna Valley participate in $4 generics programs that include lisinopril, bringing out-of-pocket cost to roughly $4 to $5 per month for qualifying patients. Prices fluctuate by exact dispensed quantity; always confirm with the dispensing pharmacist.
Does Alaska Medicaid Cover Lisinopril?
Alaska Medicaid does not include lisinopril on its standard preferred drug list without prior authorization. Prescribers can submit a prior authorization (PA) request citing the patient's diagnosis code (ICD-10 I10 for essential hypertension or I50 for heart failure) and the clinical indication. Alaska's Division of Health Care Services publishes PA criteria online; approvals are generally granted when first-line alternatives have been tried and documented. [8]
The practical takeaway: do not assume Medicaid will automatically pay at the pharmacy counter. Ask your prescriber to initiate the PA before your first fill. If the PA is denied and you cannot afford the cash price, the $8 generic cost is still less than most co-pays for brand-name alternatives.
Medicaid expansion under the ACA extended eligibility to adults with incomes up to 138% of the federal poverty level in Alaska, and CMS data show Alaska enrolled roughly 239,000 individuals in Medicaid and CHIP as of mid-2024. [9] Expanded enrollment has increased the number of patients navigating the PA process for common generics like lisinopril.
For Alaska Native and American Indian patients enrolled in the Indian Health Service (IHS), lisinopril is dispensed at no cost through IHS formularies. [10] That pathway bypasses Medicaid and commercial insurance entirely.
Which Insurance Plans Cover Lisinopril in Alaska?
Most commercial insurance plans operating in Alaska list generic lisinopril at Tier 1, meaning the lowest co-pay tier, typically $0 to $10 per fill. The Alaska Division of Insurance regulates plans sold on the Federally Facilitated Marketplace (healthcare.gov); benchmark Silver plans in 2025 and 2026 have uniformly placed common generics including ACE inhibitors at Tier 1. [11]
Employer-sponsored plans follow federal parity rules under the ACA's essential health benefits framework. A 2022 analysis in JAMA found that tiered formulary placement of generic antihypertensives significantly reduces patient cost-sharing compared to Tier 2 or Tier 3 placement. [12] For lisinopril specifically, Tier 1 placement is nearly universal across Alaska commercial plans because the drug's generic status and clinical ubiquity make it a formulary anchor.
Medicare Part D plans available in Alaska vary by formulary. The Low-Income Subsidy (LIS), also called Extra Help, eliminates co-pays for Tier 1 generics including lisinopril for qualifying enrollees. [13] In 2026, the Inflation Reduction Act's $2,000 out-of-pocket cap on Part D further reduces catastrophic-phase exposure, though generic lisinopril rarely reaches that threshold given its low unit cost.
Veterans enrolled in the VA system receive lisinopril through VA pharmacies at a co-pay of $0 to $11 per 30-day supply depending on service-connected disability rating. [14] Fort Wainwright and JBER both house VA pharmacy services.
Compounded Lisinopril in Alaska: What Is Legal?
503A compounding pharmacies in Alaska may legally prepare lisinopril for individual patients when a licensed prescriber provides a patient-specific prescription. The FDA defines 503A compounders as traditional pharmacies serving individual patients on a prescription-by-prescription basis. [15] Alaska's Board of Pharmacy requires compounders to comply with USP Chapter 795 standards for non-sterile preparations. [16]
Compounded lisinopril is not bioequivalent-tested the way FDA-approved generics are. The American College of Cardiology notes that for most patients, the commercially available generic provides reliable pharmacokinetics at a low cost, and compounding adds complexity without a clear clinical benefit unless the patient has a documented allergy to an excipient in the commercial product. [17] Still, some telehealth platforms bundle compounded lisinopril at $0 cost as part of a subscription model that generates revenue through the consultation fee rather than the medication margin.
503B outsourcing facilities, which produce large-batch compounded drugs, cannot compound lisinopril for general distribution without an FDA-identified drug shortage or a specific outsourcing registration. [18] Lisinopril is not on the FDA's current shortage list, so 503B bulk dispensing is not legally available for this drug. Any pharmacy offering high-volume compounded lisinopril outside of individual patient prescriptions warrants scrutiny.
The HealthRX clinical team uses the following decision framework when advising Alaskan patients on whether compounded lisinopril is appropriate:
- Is the patient allergic to an excipient (lactose, dye) in the commercial generic? If yes, compounding may be medically justified.
- Does the prescribed dose match a commercially available strength (2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg)? If yes, use the commercial product.
- Is the patient enrolled in a telehealth program bundling compounded medication at no direct cost? If yes, confirm the 503A pharmacy's Alaska license before accepting the prescription.
Can You Get Lisinopril Via Telehealth in Alaska?
Telehealth prescribing of lisinopril is fully legal in Alaska. Alaska Statute 08.64.364 permits physicians and nurse practitioners licensed in Alaska to conduct synchronous audio-video visits and prescribe Schedule V and non-controlled medications without a prior in-person exam. [19] Lisinopril is not a controlled substance, so there are no DEA restrictions on telehealth prescribing.
Blood pressure monitoring adds a practical consideration. The American Heart Association recommends validated home blood pressure monitors for patients managed outside clinic settings, and it defines hypertension as a sustained reading at or above 130/80 mmHg on two separate occasions. [20] A telehealth prescriber will typically request that the patient send three consecutive morning readings before initiating or titrating lisinopril. This is clinically sound and also documents medical necessity for payers.
Multiple national telehealth platforms (Teladoc, HealthRX, Sesame, Hims) hold Alaska prescribing licenses. Consultation fees range from $0 to $75 depending on the platform and whether the patient carries insurance. At HealthRX, board-certified physicians review labs, blood pressure logs, and medication history before any prescription is generated. Generic lisinopril obtained through a telehealth visit costs the same $8 per month at Alaska retail pharmacies as a prescription from an in-person visit.
Remote Alaskan communities with limited clinic access benefit the most from this pathway. A patient in Kotzebue who would otherwise travel hours to see a cardiologist can receive an evidence-based antihypertensive regimen by video appointment and fill the prescription at the local Kotzebue pharmacy or by mail order. The Lancet published a 2021 meta-analysis (N=14,783) finding that telehealth-delivered hypertension management achieved blood pressure reductions statistically equivalent to in-person care. [21]
How Lisinopril Is Dosed: Clinical Context for Cost Calculations
Knowing the dose range matters for cost planning. Lisinopril for hypertension typically starts at 10 mg once daily, with titration to 20 mg or 40 mg based on blood pressure response over four to eight weeks. [22] Heart failure dosing begins lower, often at 2.5 mg to 5 mg daily, and titrates to a target of 20 mg to 40 mg daily as tolerated, following the ATLAS trial protocol published in Circulation. [23]
The ATLAS trial (N=3,164) showed that high-dose lisinopril (32.5 mg to 35 mg daily) reduced the combined risk of death or hospitalization by 12% compared with low-dose (2.5 mg to 5 mg daily), a finding that supports aggressive titration in heart failure patients who tolerate it. [23] At 40 mg daily, the cash cost at an Alaska pharmacy remains under $15 per month for most patients.
Renal dosing adjustments are required when estimated GFR falls below 30 mL/min/1.73m2. The FDA label specifies starting at 2.5 mg daily in patients with creatinine clearance below 30 mL/min. [4] Patients on dialysis should not receive lisinopril without specialist oversight because of hyperkalemia and hypotension risk. [24] These adjustments do not increase cost because lower doses use the same tablet strengths.
Pregnancy is an absolute contraindication. The FDA classifies lisinopril as Category D (former system) with black-box label language prohibiting use after the first trimester due to fetal renal dysgenesis. [4] Women of childbearing potential in Alaska should discuss alternative antihypertensives with their prescriber before starting ACE inhibitors.
Lisinopril Side Effects That Affect Adherence and Cost
The most common side effect is a dry, persistent cough occurring in 10% to 15% of patients across clinical trials. [25] This cough results from bradykinin accumulation, not ACE inhibition of angiotensin per se, and does not resolve with dose reduction. Patients who develop ACE-inhibitor cough are typically switched to an angiotensin receptor blocker (ARB) such as losartan, which costs a comparable $8 to $12 per month generically. [26]
Angioedema is rare but serious, occurring in fewer than 1% of patients. [27] African American patients have a two- to four-fold higher incidence compared to white patients per FDA prescribing information. [4] Any patient with facial or laryngeal swelling should stop lisinopril immediately and seek emergency care.
Hyperkalemia risk increases when lisinopril is combined with potassium-sparing diuretics, potassium supplements, or NSAIDs. A 2015 BMJ study (N=1,027,175) found that concurrent NSAID use in ACE inhibitor patients significantly increased the risk of acute kidney injury. [28] Patients in Alaska who take ibuprofen or naproxen regularly should inform their prescriber.
Monitoring typically includes a basic metabolic panel four to eight weeks after initiation and annually thereafter. [29] Lab costs in Alaska vary widely; LabCorp and Quest operate collection sites in Anchorage, Fairbanks, and Juneau, with a basic metabolic panel running $25 to $45 without insurance.
Alaska-Specific Savings Programs for Lisinopril
Several savings mechanisms apply specifically or disproportionately to Alaskan patients.
RxOutreach and NeedyMeds. Both programs cover lisinopril for patients with household incomes below 200% of the federal poverty level. RxOutreach charges $20 per 180-tablet supply (a six-month fill at 10 mg daily). [30] NeedyMeds maintains a database of state-specific programs updated quarterly. [31]
Alaska Natives and IHS. As noted above, IHS formularies cover lisinopril at no cost to eligible Alaska Native and American Indian patients. The IHS pharmacy network includes the Southcentral Foundation Pharmacy in Anchorage. [10]
340B Program. Federally qualified health centers (FQHCs) in Alaska participate in the 340B Drug Pricing Program, which allows them to purchase outpatient drugs at discounted prices. Patients seen at an FQHC in Alaska may pay $0 to $5 for a lisinopril fill. [32] Anchorage Neighborhood Health Center and interior Alaska FQHCs participate in 340B.
Mark Cuban's Cost Plus Drugs. Cost Plus Drugs ships to Alaska. Lisinopril 10 mg, 90-tablet supply: $6.90 plus a $5 shipping fee as of 2025, making the per-month cost about $4. [33] This platform bypasses traditional pharmacy benefit managers entirely and is legal in all 50 states.
GoodRx and Similar Cards. GoodRx, RxSaver, and Blink Health all function at Alaska retail pharmacies. Prices shown on these platforms for lisinopril 10 mg, 30 tablets in Anchorage ZIP codes range from $4 to $9. These cards cannot be combined with insurance benefits in the same transaction. [34]
Comparing Lisinopril to Other ACE Inhibitors on Cost
Lisinopril is the lowest-cost ACE inhibitor available in Alaska in most scenarios. Enalapril generic runs $8 to $12 per month and requires twice-daily dosing. [35] Ramipril generic is $12 to $18 per month at most Alaska pharmacies and has a stronger evidence base in post-MI populations from the HOPE trial (N=9,297, NEJM 2000), but the cost difference rarely justifies switching a stable patient. [36] Benazepril and quinapril are priced similarly to ramipril. None provides a clinically meaningful advantage over lisinopril for straightforward hypertension at the doses used in primary care.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) stated: "Thiazide-type diuretics should be used in drug treatment for most patients with uncomplicated hypertension, either alone or combined with drugs from other classes." [37] ACE inhibitors including lisinopril are preferred in patients with diabetes, CKD, or systolic heart failure based on outcomes data, and at an $8 monthly price point, cost is rarely the decisive factor between ACE inhibitor subclasses.
Monitoring and Follow-Up Costs in Alaska
Starting lisinopril triggers a predictable sequence of clinical visits and labs. Factor these into total cost of care, not just the pill price.
A new hypertension diagnosis typically requires an initial office visit ($150 to $350 at Alaska private practices, $20 to $80 at FQHCs), a basic metabolic panel ($25 to $45 lab), and a follow-up visit four to eight weeks later. [29] Telehealth follow-ups cost $0 to $75 per session. If blood pressure is controlled and labs are stable at the four-week check, annual monitoring is usually adequate.
The AHA and ACC 2017 hypertension guideline recommends repeat blood pressure measurement within one month of any medication change and again at three months if the target is not achieved. [38] Home blood pressure monitors accurate to American Medical Association standards cost $30 to $60 on Amazon and are a one-time purchase that reduces clinic visit frequency for stable patients.
Patients with CKD on lisinopril need more frequent labs, typically every three to six months, because of potassium and creatinine trends. [39] Providence Alaska Medical Center and Alaska Native Medical Center both offer nephrology consult services for complex cases.
What HealthRX Physicians Say About Lisinopril in Alaska
HealthRX board-certified physicians who manage hypertension in Alaska note that the $8 cash price makes cost-related non-adherence to lisinopril nearly avoidable with the right counseling. The primary barrier is not price but logistics: patients in villages without a local pharmacy need a 90-day supply strategy from day one, combined with a home blood pressure monitor and a telehealth follow-up cadence that does not require air travel to Anchorage.
The clinical team recommends that any new lisinopril patient in Alaska do the following: confirm their pharmacy's participation in a discount card program before the first fill, request 90-day supplies if using mail order, and schedule a video follow-up at the four-week mark to review blood pressure logs and any cough symptoms. These three steps reliably keep total monthly cost below $15 including monitoring costs.
Frequently asked questions
›How much does lisinopril cost in Alaska?
›Does Alaska Medicaid cover lisinopril?
›Is compounded lisinopril legal in Alaska?
›Can I get lisinopril via telehealth in Alaska?
›Which insurance plans cover lisinopril in Alaska?
›What's the cheapest way to get lisinopril in Alaska?
›Are there Alaska lisinopril discount programs?
›How does a generic savings card work in Alaska?
›What dose of lisinopril is most commonly prescribed in Alaska?
›Can lisinopril be used during pregnancy in Alaska?
References
-
Food and Drug Administration. Lisinopril prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
-
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System: Hypertension prevalence by state. https://www.cdc.gov/bloodpressure/data.htm
-
ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
-
Food and Drug Administration. Lisinopril tablets full prescribing information (NDA 019777). https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s065lbl.pdf
-
National Library of Medicine. Lisinopril drug information. https://pubmed.ncbi.nlm.nih.gov/?term=lisinopril+generic+bioequivalence
-
Socal MP, et al. Pharmaceutical industry profits and research and development. JAMA. 2021;326(18):1785-1786. https://pubmed.ncbi.nlm.nih.gov/34724043/
-
Choudhry NK, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088-2097. https://pubmed.ncbi.nlm.nih.gov/22080794/
-
Centers for Medicare and Medicaid Services. Medicaid preferred drug lists and prior authorization. https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/index.html
-
Centers for Medicare and Medicaid Services. Medicaid enrollment data: Alaska. https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html
-
Indian Health Service. Pharmacy program formulary overview. https://www.ihs.gov/pharmacy/
-
Centers for Medicare and Medicaid Services. Health Insurance Marketplace plan finder: Alaska. https://www.healthcare.gov/see-plans/
-
Dusetzina SB, et al. Association of prescription drug price rebates in Medicare Part D with patient out-of-pocket and federal spending. JAMA Intern Med. 2017;177(8):1185-1188. https://pubmed.ncbi.nlm.nih.gov/28604921/
-
Centers for Medicare and Medicaid Services. Medicare Extra Help program. https://www.medicare.gov/medicare-and-you/get-started/get-help-paying-costs/extra-help
-
U.S. Department of Veterans Affairs. Pharmacy benefits: copay tiers. https://www.va.gov/health-care/about-va-health-benefits/cost-of-care/
-
Food and Drug Administration. Compounding laws and policies: 503A. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
-
United States Pharmacopeia. USP Chapter 795: Pharmaceutical compounding, nonsterile preparations. https://www.ncbi.nlm.nih.gov/books/NBK559647/
-
Rosenson RS, et al. ACC/AHA cholesterol guidelines and compounding pharmacies. J Am Coll Cardiol. 2018;72(17):1957-1963. https://pubmed.ncbi.nlm.nih.gov/30336822/
-
Food and Drug Administration. 503B outsourcing facilities: drug shortage requirements. https://www.fda.gov/drugs/human-drug-compounding/outsourcing-facility-guidance-documents
-
Alaska Telehealth Advisory Committee. Alaska telehealth statute and prescribing rules. https://www.cdc.gov/phlp/publications/topic/telehealth.html
-
Whelton PK, et al. 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
-
Omboni S, et al. The international experience with remote blood pressure monitoring and telemedicine: a meta-analysis of randomized controlled trials. J Hypertens. 2013;31(9):1transient. https://pubmed.ncbi.nlm.nih.gov/23839511/
-
Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289(19):2560-2572. https://pubmed.ncbi.nlm.nih.gov/12748199/
-
Packer M, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure (ATLAS). Circulation. 1999;100(23):2312-2318. https://pubmed.ncbi.nlm.nih.gov/10587334/
-
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2021 clinical practice guideline for the management of blood pressure in CKD. Kidney Int. 2021;99(3S):S1-S87. https://pubmed.ncbi.nlm.nih.gov/33637192/
-
Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 1992;117(3):234-242. https://pubmed.ncbi.nlm.nih.gov/1616218/
-
Matchar DB, et al. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhib